Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety
Abstract Background All drug marketing authorization holders have the legal obligation to collect data on the use of the products they market and to keep the labels of those products updated. As demonstrated by previous studies, many generic products have labels that are discrepant from the labels o...
Saved in:
Main Authors: | Alexandra Thoenes (Author), Luca Cariolato (Author), Julian Spierings (Author), Alexis Pinçon (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN
by: E. I. Tarlovskaya, et al.
Published: (2016) -
Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE
by: Lamia Al Ali, et al.
Published: (2022) -
Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
by: Kelly L. Hayward, et al.
Published: (2021) -
Packaging and Labeling of Pharmaceutical Products Obtained from the Internet
by: Veronin, Michael
Published: (2011) -
Evaluating the potential implications of canadian front-of-pack labelling regulations in generic and branded food composition databases
by: Christine Mulligan, et al.
Published: (2022)